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Synopsis  
Several clathrin-independent endocytic pathway components have been implicated as regulatory factors exploited 
by neonatal meningitis-causing Escherichia coli K1 bacteria to infect host cells. Here we demonstrate that the 
bacteria induce general cell ruffling, increased fluid phase uptake, and actin-, Rho GTPase- and cholesterol-
dependent invasion, which all point to a requirement for macropinocytosis as the route of uptake by the bacteria 
into non-phagocytic brain microvascular endothelial cells. 
 
Abstract  
Eukaryotic cells utilise multiple endocytic 
pathways for specific uptake of ligands or 
molecules, and these pathways are commonly 
hijacked by pathogens to enable host cell invasion. 
Escherichia coli K1, a pathogenic bacterium that 
causes neonatal meningitis, invades the 
endothelium of the blood-brain barrier, but the entry 
route remains unclear. Here we demonstrate that 
the bacteria trigger an actin-mediated uptake route, 
stimulating fluid phase uptake, membrane ruffling 
and macropinocytosis. The route of uptake requires 
intact lipid rafts as shown by cholesterol depletion. 
Using a variety of perturbants we demonstrate that 
small Rho GTPases and their downstream effectors 
have a significant effect on bacterial invasion. 
Furthermore, clathrin-mediated endocytosis appears 
to play an indirect role in E. coli K1 uptake. The data 
suggest that the bacteria effect a complex interplay 
between the Rho GTPases to increase their 
chances of uptake by macropinocytosis into 
HBMEC. 
 
Introduction 
Neonatal bacterial meningitis (NBM) is a 
life-threatening disease that progresses rapidly, 
and, despite advances in chemotherapy and 
supportive care that have reduced overall case 
numbers, at least in industrialised countries, up to 
50% of survivors are left with long-term disability 
and serious neurological dysfunction (1-4). The 
Escherichia coli strain carrying the K1 capsule is 
globally the most common cause of NBM in early 
neonates (only surpassed by Group B 
streptococcus in the developed world), and mortality 
rates remain high at 10-58% (1,3-8).   
Several bacterial virulence factors are 
thought to contribute to bacterial traversal of the 
blood-brain barrier (BBB), a critical step to penetrate 
the brain and cause the disease pathophysiology 
(9). Bacterial adherence to receptors on the surface 
of human brain microvascular endothelial cells 
(HBMEC) stimulates the activation of host 
molecules involved in a number of signalling 
pathways, including signal transducer and activator 
of transcription 3 (stat3), focal adhesion kinase 
(FAK), phosphatidylinositol-3-kinase (PI3K), protein 
kinase Cα (PKCα), p21-associated kinase 1 (PAK1) 
and the small GTPases Rac1 and RhoA (10-17). 
These signalling events result in actin 
polymerisation at the bacterial adhesion site, which 
is necessary for bacterial internalisation into 
HBMEC (18). However, the specific endocytic 
pathway hijacked by the bacterial invasion of 
HBMEC is not well characterised (19,20), and could 
contribute to identification of targets for prevention 
and therapy of E. coli meningitis.  
Here, using perturbation of endocytosis by 
overexpression of functional mutant proteins and by 
inhibition with small compound inhibitors and siRNA 
(20), in conjunction with fluorescence microscopy 
and quantitative flow cytometry-based assays, we 
demonstrate that the bacteria exploit fluid-phase 
uptake, or macropinocytic, pathways to gain entry 
into HBMEC cells. We show that this invasion 
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process is actin-mediated, that it coordinates the 
collective activity of the small GTPases of the Rho 
family (RhoA, Rac1 and Cdc42) and downstream 
effectors (including PAK1, PKC and PI3K), and 
requires cholesterol to enable phagocytic-like 
uptake of E. coli K1 into the host cells. 
 
Results 
 
E. coli K1 invasion of HBMEC is dependent upon 
actin recruitment 
The current literature has identified host-specific 
signalling molecules that contribute to E. coli K1 
interaction with HBMEC cells but remains unclear 
on the uptake pathway that leads to cell invasion 
(12,15,17,21,22). Therefore we have taken a first 
principles approach to investigate the route of 
endocytic invasion of HBMEC by E. coli K1.  
Actin polymerisation plays a role in multiple 
endocytic pathways (19,20). To study the relation of 
actin to invading bacteria, HBMEC were infected 
with E. coli K1 bacteria for 30 min, then fixed and 
stained for extracellular and intracellular bacteria 
sequentially in conjunction with phalloidin staining to 
label actin. Bacteria at the cell surface showed 
association with ruffling membrane denoted by actin 
filaments (Fig. 1A, B). Invading bacteria were 
surrounded by an actin cup (Fig. 1B). Internalised 
bacteria were found with and without actin coats 
(Fig. 1C and 1D, respectively). Quantitation of 
bacteria with and without actin at different 
timepoints following infection (Supp. Fig. 1C) 
suggests a role for actin in coating the bacterial 
vacuole during its formation and the actin then 
depolymerises once the bacterium is fully 
internalised. The role of the cytoskeleton in bacterial 
uptake was therefore further investigated using 
cytoskeleton perturbation agents. Cells were 
pretreated with several inhibitors (Fig. 1E) and then 
infected with E. coli K1 for 1 hr. The F-actin 
depolymerising agent cytochalasin D, the F-actin 
stabilising agent jasplakinolide, or blebbistatin, an 
inhibitor of myosin II which has been shown to drive 
closure of actin cups, all significantly inhibited 
bacterial invasion while nocodazole, a microtubule-
destabilising agent, had no effect (Fig. 1E). These 
results demonstrated that, while microtubules were 
not required, actin played an important role in 
bacterial entry and infection. 
Through timelapse imaging of HBMEC expressing 
an actin reporter, the host cells were found to 
respond directly to E. coli K1. Actin-based 
membrane ruffling throughout the cell surface was 
induced from 5-10 min following exposure to the 
bacteria, with the cells becoming quiescent from 25-
30 min (Supp. Movie 1; Supp. Fig. 1A, B). Following 
this time series, a z-stack of one cell shows an 
internalised bacterium (Supp. Fig. 1B). Quantitation 
of actin showed that ruffling was induced by E. coli 
K1 but not by non-pathogenic E. coli K-12 (Supp. 
Fig. 1D). This suggests that the bacteria induce 
actin mobilisation to upregulate the cell’s uptake 
pathways to enable cell entry. 
 
Involvement of actin-modulating small GTPases 
in E. coli K1 invasion 
Previous publications have implicated the actin 
recruitment proteins RhoA and Rac1 with putative 
roles in E. coli K1 invasion (12,15,17). The Rho 
GTPases cycle between a GTP-bound, active, state 
and a GDP-bound, inactive, state. Activity can be 
modulated by expression of dominant mutants 
which alter nucleotide binding. To study involvement 
of the Rho family of GTPases during bacterial 
invasion quantitatively, HBMEC were transiently 
transfected with GFP chimaeric constructs of the 
GTPases and their related mutants. A plasmid 
encoding GFP alone was transfected into HBMEC 
as a transfection control. Transfected cells were 
infected with E. coli K1 bacteria expressing mCherry 
(K1-Cherry) for 2 hr, incubated for 1 hr in media 
containing gentamicin to kill extracellular bacteria, 
processed for imaging, and then tiled z-stack 
confocal images were acquired to obtain a large 
unbiased field. Quantification of GFP-positive cells 
with intracellular K1-Cherry showed that cells 
transfected with activated RhoA (RhoA V14) and 
Rac1 (Rac1 L61) both had significantly higher 
number of cells with internalised bacteria, while 
cdc42 activated mutant (cdc42 V12) had no 
significant effect on bacterial uptake when 
compared to wild type but did significantly increase 
number of cells with bacterial uptake when 
compared to the inactive mutant, cdc42 N17 and the 
GFP control (Fig. 2A). Furthermore, the inactive 
mutants of RhoA and Rac1 showed significant 
reduction in number of infected cells relative to the 
GFP control. In the case of all GTPase constructs 
some internalised bacteria could be seen to 
colocalise with a concentrated ring of GFP stain 
while others were found without any specific 
colocalisation (Fig. 2B,C shows cdc42 as an 
example of this). As bacterial uptake was not tightly 
synchronised, this would suggest that during 
invasion the bacteria transiently associate with 
membranes to which the small GTPases are 
recruited and these are then released from the 
membrane as the bacterial vacuole matures.  
The effect of inhibition of downstream effectors of 
the Rho GTPases including p21-activated kinase 1 
(PAK1), protein kinase C (PKC) and 
phosphatidylinositol‑3-kinase (PI3K) with IPA-3, 
GF109203X and wortmannin, respectively, was next 
tested. These inhibitors were found to significantly 
block entry of bacteria into cells (Fig. 2D). In 
comparison, transferrin uptake, used as a marker 
for clathrin-mediated endocytosis (CME), was not 
inhibited by any of the kinase inhibitors tested, 
indeed PKC inhibition led to increased transferrin 
uptake. Furthermore, uptake of labelled dextran, a 
marker for fluid phase uptake, was found to be 
markedly inhibited only by wortmannin treatment 
(Fig. 2D). To further investigate activation of 
signalling pathways, total cell lysates were analysed 
by Western blot with antibodies to phosphorylated 
Akt, a downstream effector of PI3K (Fig. 7C,D). As 
found in previous studies, Akt was transiently 
phosphorylated following infection of HBMEC (16). 
Together these results support a role for Rho 
GTPases, and their downstream effectors, in E. coli 
K1 invasion of HBMEC. 
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E. coli K1 invasion of HBMEC is cholesterol-
dependent 
The involvement of actin, the membrane ruffling and 
the importance of nonspecific Rho GTPase activity 
and the regulatory kinases all point to 
macropinocytosis or another clathrin-independent 
pathway as a potential entry mechanism for E. coli 
K1 into the endothelial cells (23). As cholesterol is 
required for membrane ruffling, lipid raft dependent 
endocytosis (such as caveolae) and 
macropinocytosis (24-26), the effect of HBMEC 
treatment with methyl-β-cyclodextrin (MβCD), a 
reagent used to deplete membrane cholesterol, was 
tested on the uptake of E. coli K1. Bacterial invasion 
was significantly inhibited by >95% upon cholesterol 
depletion (Fig. 3A). Conversely, cholesterol loading 
of HBMEC cells through the addition of water-
soluble cholesterol (MβCD-cholesterol complexes) 
increased bacterial invasion by 79%±16% (Fig. 3A). 
These data indicated the importance of cholesterol 
and associated lipid rafts in E. coli K1 invasion of 
HBMEC. 
As a comparison, the effect of cholesterol depletion 
with MβCD and cholesterol loading on the endocytic 
markers transferrin (for clathrin-mediated uptake) 
and dextran (for fluid phase uptake) was also 
explored (Fig. 3B). Cholesterol depletion had an 
inhibitory effect on dextran uptake while transferrin 
uptake was enhanced by cholesterol depletion, both 
with dose-dependent effect. Therefore E. coli K1 
uptake again more closely resembled the dynamics 
of the fluid phase pathway in response to 
cholesterol depletion treatment. 
 
E. coli K1 invasion of HBMEC is caveolin-1-
independent 
Caveolae-mediated endocytosis is highly sensitive 
to cholesterol-depleting agents (27), and has 
previously been implicated in E. coli K1 invasion of 
HBMEC (21,22). To investigate this possible uptake 
route, HBMEC were infected with E. coli K1-Cherry, 
fixed at indicated time points post infection, and 
immunolabelled for caveolin-1. After 30 min of 
infection, some bacteria could be found localised in 
compartments weakly labelled for caveolin-1 (Fig. 
4A, white arrows). However, quantification showed 
that only about 4% of the bacteria were closely 
associated with caveolin-1 after 30 min infection 
(Fig. 4B), which was further reduced to about 1% at 
2 hr post infection (p.i.) and continued to diminish at 
later timepoints. Therefore, association of E. coli K1 
with caveolin-1 seemed to be a rare event, 
occurring at early time points of infection, 
presumably during internalisation.  
While these data suggested that caveolae-mediated 
uptake was not a major route of invasion for E. coli 
K1 into HBMEC, it was possible that the interaction 
with caveolin may be too fleeting to record. 
However, expression of a dominant caveolin-1 
mutant that inactivates caveolae-dependent uptake 
(caveolin-1-Tyr14; 28,29) had no effect on E. coli K1 
invasion into HBMEC (Fig. 4C). Furthermore, 
bacterial invasion of either caveolin-1 knockout 
(Cav1 KO) endothelial cells compared to wild type 
cells (WT), or caveolin-1 knockdown in HBMEC with 
siRNA, in both cases revealed that loss of caveolin-
1 resulted in a significant increase in E. coli K1 
invasion (Fig. 4D and 4E, respectively), indicating 
that the presence of caveolin-1 was not essential for 
bacterial entry. As caveolin-2 expression is 
suppressed by knockdown of caveolin-1, it is not 
possible that this is acting in a compensatory 
manner (30-33). 
Overall, our data therefore indicated that E. coli K1 
invasion of HBMEC is not dependent on caveolae-
mediated endocytosis. 
 
E. coli K1 invasion of HBMEC is dynamin-
dependent 
Many endocytic routes, including clathrin-mediated, 
caveolae and some lipid-raft-dependent uptake 
routes, require recruitment of dynamin (Dyn), a 
large GTPase necessary for pinching off transport 
intermediates from the plasma membrane. 
Overexpression of the GDP-locked dynamin mutant 
inhibits these uptake routes (34-36). We therefore 
hypothesised that, if the bacteria invaded HBMEC in 
a dynamin-dependent manner, overexpression of 
Dyn2(aa)K44A (37), would inhibit E. coli K1 invasion 
of HBMEC. HBMEC were transiently transfected 
with GFP-tagged Dyn2 chimaeric constructs, with a 
plasmid encoding GFP alone used as a transfection 
control. Following infection with K1-Cherry for 30 
min, bacteria at the cell surface showed no specific 
colocalisation with dynamin, nor were any 
intracellular bacteria encircled by dynamin stain 
(Supp. Fig. 2C) as has been seen previously with 
invading bacteria such as Listeria monocytogenes 
(38). Quantification of GFP-positive cells with 
intracellular K1-Cherry showed no inhibition of 
bacterial invasion in cells overexpressing 
Dyn2(aa)K44A GFP (Fig. 5A), contrary to what 
would be expected for a dynamin-dependent uptake 
route. Repetition of the experiments with Dyn1 
constructs confirmed these results, and no reduction 
in E. coli K1 invasion of HBMEC overexpressing 
dominant negative Dyn1 (Dyn1K44A-GFP) was 
seen (Fig. 5A). In fact, there was a modest 
enhancement in E. coli K1 internalisation into these 
cells compared to cells expressing wild type Dyn1, 
although it was not statistically significant. 
To demonstrate that the dynamin mutant had a 
significant effect on the dynamin-dependent uptake 
pathways in these cells, a control transferrin uptake 
experiment was performed with either Dyn2(aa)WT-
GFP or Dyn2(aa)K44A-GFP expressing cells. Supp. 
Fig. 2A and 2B demonstrate that transferrin uptake 
is abrogated in cells expressing GFP-tagged mutant 
Dyn2. Furthermore, when the chimaeric Dyn2 
constructs were expressed in HBMEC and the cells 
were infected with L. monocytogenes, uptake was 
inhibited by both the dominant mutant and by 
overexpression of the wild type Dyn2 construct itself 
(Fig. 5B).  
We further tested the role of dynamin by using the 
inhibitory agent dynasore to inhibit dynamin in the 
E. coli K1 invasion assay. Only at high 
concentration was dynasore found to inhibit E. coli 
K1 uptake (Fig. 5C). In contrast, dynasore had a 
significant impact on Listeria invasion at the lowest 
concentration tested (Fig. 5C). At high 
concentrations dynasore inhibits fluid-phase 
endocytosis in a dynamin-independent manner 
(Supp. Fig. 3A; 39), which may explain why E. coli 
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K1 invasion is only affected at high concentration. 
The effect of Dyn2 depletion through siRNA 
transfection on E. coli K1 uptake was investigated. 
Relatively inefficient knockdown was achieved in the 
HBMEC cells, however, with a 45% reduction in 
Dyn2 levels, a 40% reduction in bacterial invasion 
was seen (Fig. 5D).  
This suggests that, while dynamin had some effect 
on E. coli K1 invasion, it was not as clear a role as 
seen with L. monocytogenes infection. 
 
E. coli K1 upregulates macropinocytosis and 
utilises the pathway to invade HBMEC 
To further explore the role of macropinocytosis in 
E. coli K1 invasion, the effect of bacteria on fluid 
phase uptake was investigated. Internalisation of 
fluid by macropinocytosis can be stimulated with 
high levels of serum (40,41). FITC-dextran, 
employed as a marker for fluid phase uptake during 
macropinocytosis, was added to serum-starved 
HBMEC in low or high serum medium, or in 
conjunction with bacterial infection, and cells were 
then analysed by flow cytometry for FITC content 
(Fig. 6A). The experimental medium used for 
bacterial invasion had a low serum content, and the 
high serum experimental medium was employed as 
a positive control for macropinocytic uptake in 
HBMEC (40,41). Analysis of FITC levels revealed 
that high serum induced a small but reproducible 
and significant shift in median FITC measurements, 
indicative of increased fluid phase uptake in cells 
stimulated with serum (Fig. 6A). FITC-dextran 
internalisation was also increased relative to low-
serum media alone upon exposure to E. coli K1 
(Fig. 6A), indicating that bacteria increase fluid-
phase uptake in HBMEC.  
Activity of the Na+/H+ exchanger at the plasma 
membrane modulates Rho GTPases and this can 
be inhibited by the amiloride-derivative 5-(N-Ethyl-
N-isopropyl) amiloride (EIPA) thereby inhibiting 
macropinosome formation (42). Another reagent 
often used as a macropinocytosis inhibitor is 
rottlerin, potentially acting through PKC although its 
mechanism of action is unclear (23,43). Treatment 
of HBMEC with either EIPA or rottlerin had a strong 
inhibitory effect on fluid-phase uptake as measured 
by labelled 10 kDa dextran internalisation (Fig. 6B). 
Clathrin-mediated uptake of transferrin was not 
inhibited by these treatments, and rottlerin induced 
a strong increase in transferrin uptake compared to 
the control. EIPA and rottlerin reduced E. coli K1 
invasion by 95% and 99%, respectively (Fig. 6B), 
indicating that E. coli K1 requires macropinocytosis 
in order to infect HBMEC cells. When cells were 
infected with E. coli K1 in the presence of Alexa 
Fluor 647-dextran for 30 min, fixed and stained for 
extra- and intracellular bacteria and then imaged, 
labelled dextran colocalised with internalised 
bacteria (Fig. 6C). Quantification of internalised 
bacteria associated with dextran following 30 min 
uptake showed that 59.7±4.9% bacteria were in 
dextran-positive compartments (Fig. 6D). These 
data indicated that the bacteria entered through the 
macropinocytic pathway.  
 
Clathrin-mediated endocytosis is indirectly 
involved in E. coli K1 invasion  
Although clathrin has not been found associated 
with bacterial vacuoles as visualised by microscopy 
(18), the involvement of clathrin-mediated uptake in 
E. coli K1 invasion has not been quantitatively 
measured. Chlorpromazine (CPZ) is a 
pharmacologic inhibitor of clathrin-mediated 
endocytosis but has off-target effects that can vary 
between cell types (44-46). When the effect of CPZ 
on bacterial invasion of HBMEC was assessed, no 
significant inhibition of E. coli K1 invasion was found 
across a range of concentrations (Fig. 7A). Although 
there appeared to be decreased efficiency in 
invasion with lower concentrations of CPZ, this was 
not statistically significant. In contrast, invasion of L. 
monocytogenes, which enters cells utilising the 
CME pathway components (38,47), was inhibited by 
CPZ in dose-dependent manner (Fig. 7A). When the 
effect of CPZ on endocytic markers was tested, 
transferrin uptake showed a small but significant 
inhibitory effect, while dextran was unaffected 
(Supp. Fig. 3A). In support of the earlier study by 
Prasadarao et al (18), we also found no association 
of clathrin with bacterial vacuoles containing E. coli 
K1, while Listeria bacteria were found to colocalise 
with clathrin (Supp. Fig. 3B). This supports E. coli 
K1 invasion through a non-clathrin-mediated 
pathway.  
Specific targeting of clathrin-mediated uptake 
through siRNA depletion of adaptor protein complex 
2 (AP2) resulted in a decrease of 80% in E. coli K1 
invasion (Fig. 7B). This somewhat contradicted the 
CPZ result and suggested that clathrin might be the 
major uptake pathway for E. coli K1. However, when 
cells were also treated with EIPA, to additionally 
block macropinocytosis, bacterial invasion was 95% 
inhibited (Fig. 7B).  
When the effect of AP2 depletion on E. coli-
stimulated Akt phosphorylation was examined 
through immunoblotting of cell lysates (Fig. 7C,D), 
this revealed that Akt phosphorylation was greatly 
reduced compared to control (approximately 50% 
level of phospho-Akt) at 30 min post infection. 
This would suggest that a long-term block in 
clathrin-mediated uptake, as in an siRNA 
transfection timecourse, reduced an important 
plasma membrane component for E. coli K1 
invasion, diminishing both invasion and signalling. 
Since trafficking through clathrin-independent 
endocytic routes has been found to exhibit some 
dependency on clathrin-mediated endocytosis (48), 
this may explain the apparent effect of CME blocks 
on E. coli K1 invasion. 
 
Discussion 
In order to establish meningitis, E. coli K1 
must induce its uptake by the endothelial cells that 
form the blood-brain barrier, and then traverse these 
cells. These microvascular endothelial cells are 
known to have very few endocytic vesicles (49), 
which may derive from any of the clathrin-
dependent or -independent endocytic pathways 
(19). Therefore, in order to gain entry to the cells, 
the bacteria must induce huge changes in uptake 
dynamics. The actin-mediated membrane ruffling 
seen here at the cell surface points to bacteria-
induced upregulation of macropinocytic activity. This 
enables a phagocytic-like uptake of the bacteria. 
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The requirement for actin in E. coli K1 
uptake into HBMEC has been demonstrated by both 
accumulation of host actin to the membrane 
underlying invading bacteria, by the increased actin 
mobilisation seen in the live imaging, and by the 
inhibitory effects on bacterial invasion by actin 
inhibitors (here and (18)). The small GTPases of the 
Rho family (Rho, Rac1 and cdc42) are frequently 
involved in the signalling cascade which regulates 
actin filament dynamics leading to membrane 
ruffling (23). The bacterial toxin cytotoxic necrotizing 
factor 1 (CNF1), produced by pathogenic E. coli 
bacteria including E. coli K1, coordinately activates 
Rho, Rac and Cdc42 (12,50,51), which in turn 
upregulate generalised ruffling activity and actin 
recruitment, the processes which underlie induction 
of macropinocytosis. Previous investigations have 
suggested that both RhoA (through CNF1) and 
Rac1 (through outer membrane protein A, OmpA) 
play a role in E. coli K1 uptake (12,15,17). Here we 
have demonstrated that activated RhoA, Rac1 and 
cdc42 can promote E. coli K1 invasion, and that this 
may be linked to PAK1 and PI3K activation. 
Signalling through the PI3K pathway culminates in 
phosphorylation of Akt, which has been found to 
also require PAK1 and PKCα for efficient activation 
(52,53). CNF1 from E. coli K1 may therefore act in 
concert with OmpA to switch on the collective 
activity of the GTPases and their downstream 
effectors to bring about cytoskeletal rearrangement 
to form macropinosomes (Fig. 8) (12,17,18). Cdc42 
and Rac1 both constitute major regulators of 
macropinocytosis (20,23,54), but while RhoA has 
not been considered a factor in macropinocytosis, it 
has been implicated in lipid raft-mediated endocytic 
pathways (19,20). Furthermore, the precedent for 
additional Rho GTPase family members to be 
required for macropinocytosis in concert with Rac1 
and Cdc42 has been shown with Salmonella 
invasion of non-phagocytic cells (55), where RhoG 
was required, together with Rac1 and Cdc42, to 
orchestrate actin modulation required for bacterial 
entry. The ability to manipulate bacterial invasion by 
all the Rho GTPases suggests that the bacterial 
invasion requires a dynamic activation of actin 
recruitment to upregulate macropinocytosis in order 
for the bacteria to force cell engulfment. 
Virus induction of macropinocytosis is often 
associated with activation of signalling pathways 
that lead to changes in actin dynamics, causing 
membrane ruffling and increased fluid phase 
uptake, which results in internalisation of particles 
including viruses as well as fluid (54,56). Plasma 
membrane deformation during macropinocytosis 
differs from phagocytosis in that the latter 
specifically forms a membrane cup around an object 
targeted by the cell for uptake, while the former 
involves indiscriminate cell-wide membrane ruffling. 
Different macropinocytic mechanisms show distinct 
membrane formations and, while some 
macropinocytic events rely on induction of circular 
ruffling, others are characterised by plasma 
membrane deformation as either flat lamellipodial 
sheets or as blebs (57,58). In our data, bacterial 
addition resulted in non-specific membrane ruffling 
with no evident circular formations. We also saw 
increased fluid uptake upon exposure of the 
endothelial cells to E. coli K1 which concurs with the 
electron micrographs of internalised bacteria in the 
previous study by Prasadarao et al that showed 
internalised bacteria surrounded by notable 
amounts of fluid in their vacuoles (18). Together, the 
transient membrane ruffling response of the cells to 
the bacteria, involvement of multiple Rho GTPases, 
stimulated dextran uptake and inhibition by 
macropinocytic inhibitory reagents all point to 
indiscriminate stimulation of particle uptake 
mechanisms to enable bacterial invasion by 
macropinocytic-like processes. This is also termed 
triggered phagocytosis (56). 
Methyl-β-cyclodextrin has been shown 
before to inhibit E. coli K1 entry into HBMEC (22). 
The mechanism of this inhibition is unknown and 
could be due to effects on cell surface receptor 
expression such as by receptor sequestration or by 
inhibition of receptor-mediated invasion. However, 
new data shown here demonstrates that cholesterol 
loading of the cells has the opposite effect, where 
the bacteria can much more readily gain entry to the 
cells. This cannot be easily explained by a large 
increase in receptors on the surface and suggests 
that the levels of cholesterol in the cell membrane 
may alter the environment in another way to 
facilitate bacterial invasion. Depletion of cholesterol 
from membranes might remove some important 
receptor from the cell membranes, hence preventing 
uptake, however cholesterol loading would not be 
expected to cause upregulation of an equivalent 
receptor during the short treatment time to explain 
the increased uptake and therefore this points to a 
more direct effect of cholesterol itself. 
While previous studies of E. coli K1 
invasion have implicated a role for caveolae for 
bacterial entry into HBMEC (21,22), we could find 
no evidence for a role for caveolae through both 
direct visualised association of a caveolin coat, 
through inhibitory effects of dominant mutants, 
siRNA knockdown, and through use of a knockout 
cell line. We instead found increased bacterial 
invasion in cells with reduced caveolin-1. Since 
cholesterol is found concentrated in caveolae, they 
may have a role in regulating levels of cholesterol 
and other lipids in the plasma membrane (59,60). In 
caveolin null cells, there is no difference in total 
plasma membrane cholesterol compared to wild 
type cells	   (61,62), suggesting that the cholesterol 
usually sequestered within caveolae is distributed 
instead throughout the plasma membrane. This 
might lead to a membrane environment equivalent 
to our cholesterol loading experiment, that also led 
to increased invasion of HBMEC by E. coli K1. In 
agreement with this, in cells depleted of caveolin-1 
fluid phase uptake is upregulated (63). Similarly, 
increased membrane microdomain mobility in 
caveolin null cells is attributed to enhanced invasion 
of Staphylococcus aureus (64). 
Previously, clathrin has not been 
implicated in E. coli K1 uptake. Here we found an 
apparent effect with inhibition of clathrin-mediated 
endocytosis through both pharmacological inhibitors 
(of clathrin and dynamin) and through siRNA 
knockdown of AP2, the clathrin adaptor complex, 
although an earlier study, and our own data, could 
find no colocalisation with clathrin (18). Although the 
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chemical inhibitors used in this study are known to 
have off-target effects (44-46), the effects seen on 
Listeria uptake much more closely followed 
transferrin uptake as would be expected given its 
association with clathrin on entry, shown here and 
(38,47). However, in each case, E. coli K1 invasion 
dynamics showed very different behaviour. 
Dynasore inhibited E. coli K1 entry only at high 
concentrations. This reagent has been previously 
found to affect macropinocytosis, attributed to its 
inhibition of membrane ruffling and fluid phase 
uptake, which is dynamin-independent (39,65). 
Therefore this would explain its impact on uptake by 
E. coli K1 via a macropinocytic invasion route. 
Dynamin itself does not have a direct effect on 
macropinocytosis (39,40). That AP2 and dynamin 
knockdown have such a strong effect on E. coli K1 
invasion may be due to an indirect effect such as 
preventing cell surface recycling of important 
plasma membrane protein components through 
CME (48). Alternatively, long term depletion of CME 
components could have an effect on cholesterol 
homeostasis by preventing internalisation of LDL at 
the plasma membrane (Fig. 8; 65). 
Blood bacteraemia must reach a threshold 
before the bacteria gain access to the central 
nervous system (66). As the blood-brain 
endothelium has a high resistance to transport, it 
therefore appears that the E. coli K1 bacteria target 
a network of signalling molecules in order to 
stimulate macropinocytosis which the cell ordinarily 
uses as a broad and general mechanism for 
sampling fluid and solutes. By making use of the 
pleiotropic regulation of the host’s macropinocytic 
machinery, the bacteria can thereby increase their 
own chances of uptake into the cells of the blood-
brain barrier and thus invasion into the brain.  
 
Materials and Methods 
 
Cell culture and bacteria 
Mammalian cells were maintained in a 
humidified 37°C, 5% CO2 tissue culture incubator. 
Human brain microvascular endothelial cells 
(HBMEC) (67) were grown in RPMI-1640 
supplemented with 20% (v/v) heat-inactivated foetal 
bovine serum (FBS) (Biosera, Ringmer, UK), 2 mM 
L-glutamine, 1 mM sodium pyruvate, 100 µg/ml 
streptomycin, 100 units/ml penicillin, non-essential 
amino acids (Gibco, Invitrogen, Paisley, UK), and 
vitamins (Gibco). Primary mouse lung endothelial 
cells (MLEC) (a kind gift from B.J. Nichols, MRC 
Laboratory of Molecular Biology, Cambridge, UK) 
were grown in 50:50 low glucose Dulbecco’s 
Modified Eagles Medium (DMEM) and Ham’s F12 
supplemented with 20% (v/v) FBS, 0.00125% (w/v) 
heparin, 2 mM L-glutamine, 100 µg/ml streptomycin, 
and 100 units/ml penicillin, 0.1 mg/ml endothelial 
cell growth supplement (AbD Serotec, Oxford, UK). 
Reagents were purchased from Sigma-Aldrich 
(Poole, UK) unless otherwise stated. 
Bacterial strains used were E. coli K1 
(E44), which is a spontaneous rifampicin-resistant 
mutant of RS218 strain isolated from a neonatal 
meningitis patient (68), and E. coli HB101 (K-12), 
grown in Luria-Bertani (LB) broth at 37°C with 
shaking. E. coli K1 constitutively expressing 
mCherry (K1-Cherry) were described previously and 
are not compromised for invasion in HBMEC (69). 
Listeria monocytogenes (a kind gift from G. J. 
Bancroft, LSHTM) was grown in brain heart infusion 
(BHI) broth. 
 
Antibodies 
Antibodies used were: monoclonal mouse anti-β-
actin (clone AC-15), monoclonal mouse anti-
adaptin α (clone 8; BD Biosciences, Oxford, UK), 
monoclonal rabbit anti-pan Akt (Cell Signaling 
Technology, Danvers MA), polyclonal rabbit anti-
phospho Akt (Ser473) (Cell Signaling Technology), 
polyclonal rabbit antibody to caveolin-1 (BD 
Biosciences), monoclonal mouse anti-clathrin (clone 
X22 was a kind gift from FM Brodsky, UCL) 
polyclonal rabbit anti-dynamin 2 (Genetex Inc. Irvine 
CA), polyclonal rabbit antibody to E. coli O18 (Mast 
Group, Bootle, UK), FluoProbes®-secondary 
antibodies (Interchim, Cheshire Science Ltd., 
Chester, UK), HRP-conjugated goat anti-mouse and 
HRP-conjugated goat anti-rabbit (Bio-Rad, Hemel-
Hempstead, UK). 
 
Gentamicin survival assay  
HBMEC were grown to confluency in 24-
well tissue culture plates, three wells for each 
condition. Experiments were conducted in low-
serum media (RPMI-1640 supplemented with 5% 
FBS, and 2 mM L-glutamine), except where 
indicated. Cells were pretreated for 30 min with 
reagents and infected at multiplicity of infection 
(m.o.i.) of ~100 with mid-log phase E. coli K1, K1-
Cherry or K-12, or with m.o.i. 10 with mid-log 
L. monocytogenes, as indicated. To facilitate 
bacterial association with cells, bacteria were 
centrifuged onto cells at 500 g for 5 min. Cells were 
infected for 1 hr at 37°C, unless indicated otherwise 
in the text, after which infected cells were overlaid 
with experimental media containing 100 µg/ml 
gentamicin for 1 hr at 37°C to kill extracellular 
bacteria. Cells were lysed with 0.3% (w/v) SDS in 
PBS to release E. coli or with 0.5% (w/v) saponin in 
PBS to release L. monocytogenes, and the number 
of viable bacteria released from the cells was 
assessed by bacterial colony-forming units (cfu) 
ascertained by titration on LB agar plates (or BHI 
agar plates for L. monocytogenes) and overnight 
incubation at 37°C. Results were expressed as the 
number of intracellular bacteria per cell relative to 
control. At least three independent experiments 
were undertaken. 
 
Fluid phase and clathrin-mediated uptake 
assays 
Alexa-Fluor® 647 transferrin (Molecular 
Probes, Invitrogen) or Alexa Fluor® 647 10 kD 
fixable dextran (Molecular Probes, Invitrogen) at 
final concentration of 25 µg/ml or 0.5 mg/ml, 
respectively were incubated with HBMEC for 30 min 
at 37°C, before washing at 4°C to arrest 
endocytosis. Transferrin-labelled cells were treated 
with an acid wash (0.5% acetic acid, 0.05 M NaCl, 
pH 3.0) for 2 min at 4°C to remove surface label and 
washed in RPMI to neutralise the acid. Cells were 
trypsinised, washed, and resuspended in FACS 
buffer (1% FCS in PBS).   
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Acquisition of flow cytometry data was 
performed on a BD™ LSRII (BD Biosciences, 
Oxford, UK) using appropriate laser lines, and 
analysed using FlowJo software (version 9, Tree 
Star, Ashland, OR, USA). 
 
Pharmacological inhibitors 
For cholesterol depletion or loading, cells 
were washed twice with RPMI (without serum, SFM) 
and pretreated at 37°C for 30 min with MβCD 
(methyl-β-cyclodextrin) or cholesterol-MβCD, 
respectively, in RPMI at a concentration range of 1-
10 µM before addition of bacteria or labelled 
endocytic marker and assayed as described. For 
other chemical treatments, cells were pretreated 
with the reagent or control vehicle in experimental 
media for 30 min, prior to infection with E. coli K1 or 
labelled endocytic marker in the continuing 
presence of the reagent. Blebbistatin was used at 
25-100 µM; chlorpromazine at 3-30 µM; 
cytochalasin D at 1-10 µM; dynasore at 80 µM or at 
concentration shown; EIPA at 80 µM; GF109203X 
at 25 µM; IPA-3 at 50 µM; jasplakinolide at 
0.5-5 µM; nocodazole at 1 µg/ml; rottlerin at 50 µM; 
wortmannin at 10 µM. Reagents were tested for 
potential toxicity on HBMEC by trypan blue 
exclusion, and their effects on bacterial viability 
were tested by cfu analysis. Treatments with 
cholesterol-manipulating and macropinocytic 
inhibitory reagents were repeated with 
L. monocytogenes bacteria but the reagents were 
found to be bacteriostatic for this species and the 
results could not be interpreted. 
 
Immunofluorescence and imaging 
HBMEC were grown on 13 mm no. 1 glass 
coverslips (VWR, Lutterworth, UK) and infected as 
above with either E. coli K1 or K1-Cherry at moi 
~100. Cells were fixed in 3% formaldehyde/PBS for 
15 min at room temperature (RT), washed with PBS 
and then incubated for 10 min in 50 mM NH4Cl in 
PBS. Cells were washed in 5% FCS/PBS (wash 
solution) and then were labelled sequentially with 
primary and secondary antibodies diluted in wash 
solution containing 0.2% saponin, each with 1 hr RT 
incubations. For actin staining, cells were labelled 
with phalloidin-TRITC at 10 µg/ml for 1 hr RT. For 
differential staining of intra- and extra-cellular 
bacteria, cells were initially stained with anti-E. coli 
O18 and then FluoProbes®-642 donkey anti-rabbit 
IgG without a permeabilisation agent, before 
proceeding to a second sequential staining step in 
the presence of saponin with anti-E. coli O18 and 
the related secondary tagged with another 
fluorophore (usually FluoProbes®-546) in 
combination with other antibodies as appropriate. 
Nuclei were stained with 1 µg/ml DAPI and cells 
were mounted onto a microscope slide with 
Confocal Matrix (Micro-Tech-Lab, Austria) or 
Fluoromount-G™ (eBioscience, Hatfield, UK).  
To visualise dextran uptake with bacteria, 
cells were infected with mid-log E. coli K1 at moi 
~100 in the presence of 500 µg/ml Alexa Fluor® 647 
10 kD fixable dextran for 30 min, then fixed and 
stained for intra- and extracellular bacteria. 
For transferrin uptake, Alexa Fluor® 555 
transferrin (Gibco, Invitrogen) at 25 µg/ml was 
incubated for 30 min at 37°C with HBMEC 
transfected with dynamin 2-GFP plasmids, cells 
were fixed in 2% PFA and visualised.  
Samples were observed with an inverted 
Zeiss LSM 510 confocal laser-scanning microscope 
(Carl Zeiss Ltd, Cambridge, UK) with appropriate 
lasers. To avoid potential experimental bias, tile z-
stack images were acquired under software control. 
Images were processed with ImageJ (W. Rasband, 
National Institutes of Health, Bethesda, MD) and 
Adobe Photoshop. 
 
Transient transfection of HBMEC 
Plasmids encoding Dyn2(aa)WT-GFP and 
Dyn2(aa)K44A-GFP (37) were kind gifts from M.A. 
McNiven (Mayo Clinic, Rochester, MN, USA), 
Dyn1WT-GFP and Dyn1K44A-GFP were 
generously provided by H.T. McMahon (MRC LMB, 
Cambridge, UK), Cav1-GFP (70) was from B.J. 
Nichols (MRC LMB, Cambridge, UK), and the GFP-
tagged caveolin-1 mutant constructs were kindly 
provided by M.O. Parat (University of Queensland, 
Australia) (71). RhoA-GFP plasmid constructs and 
pGFP wt Rac1 and pGFP L61 Rac1 were kind gifts 
from A.J. Ridley (King’s College, London, UK) (72); 
pGFP-Rac1N17 from P. Fort (CNRS Montpellier, 
France) (73); cdc42-GFP constructs were from B.J. 
Nichols (74); Lifeact-GFP was from M. Parsons 
(75,76). pEGFP-N1 (Clontech, BD Biosciences) was 
used as the soluble GFP control and pLDLR A18 
GFP, a kind gift from G.E. Kreitzer (University of 
Cornell, NY, USA) (77), as the membrane-bound 
GFP control. 
For plasmid DNA transfection, HBMEC 
were seeded onto glass cover slips, grown to 
approximately 80% confluency, and were 
transfected using jetPRIMETM transfection reagent 
(Polyplus-transfection SA, Illkirch, France) 
according to the manufacturer’s instructions. 
Approximately 20 hr post-transfection, cells were 
infected with K1-Cherry bacteria and imaged as 
described (69). Briefly, following infection as above, 
cells were incubated in experimental medium 
containing 100 µg/ml gentamicin at 37°C for 1 hr. 
Coverslips were washed and mounted onto a low-
tech rubber gasket imaging chamber with 
approximately 35 µl imaging medium [RPMI-1640 
without phenol red supplemented with 5% (v/v) 
FBS, 2 mM L-glutamine, 25 mM HEPES (pH 7.4)] 
(69,78). Live cells were held at 37°C on the 
microscope stage and tile z-stack images were 
acquired. Infection was quantified manually by 
counting the number of GFP positive cells with 
intracellular bacteria (n ≥ 30 GFP-positive cells). 
For live cell time series of E. coli K1 infection, K1-
Cherry bacteria were centrifuged onto transfected 
HBMEC and cells were immediately transferred to 
the microscope stage and imaged continuously at 
37°C for 1 hr. Images and movies were generated 
and analyzed using the Zeiss LSM software and 
ImageJ software. 
 
siRNA transfection 
Non-targeting siRNA or AP2A1, caveolin-1 
and dynamin 2 siRNA (all SMARTpool siGENOME 
siRNA from Dharmacon, GE Healthcare) were 
delivered to cells at a final concentration of 50 µM, 
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using Lipofectamine RNAiMAX. Assays were 
carried out after 48 hr. Knockdown efficiency was 
ascertained by lysis of control cell wells in RIPA 
buffer (140 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 
1% Triton X-100, 0.1% sodium deoxycholate, 0.1% 
SDS, 10 mM Tris, pH 8.0) supplemented with 
protease inhibitor cocktail (ThermoFisher Scientific, 
Waltham MA), followed by protein gel 
electrophoresis, Western blotting and detection of 
HRP-conjugated secondary antibodies with 
Pierce™ ECL Western Blotting Substrate 
(ThermoFisher Scientific). 
 
Macropinocytosis assay 
HBMEC were grown to confluency in 12-
well plates, then incubated in experimental media 
for 1 hr prior to refreshment with experimental 
media supplemented with 200 µg/ml FITC-dextran 
(10 kD dextran conjugated to FITC) ± mid-log E. coli 
K1 at moi ~100 for 2 hr at 37°C. As a positive 
control HBMEC cells were incubated with 
experimental media containing 20% FCS and 
200 µg/ml FITC-dextran (41). Following the infection 
period, cells were washed and incubated for 1 hr 
with fresh experimental media supplemented with 
100 µg/ml gentamicin, after which they were 
washed, trypsinised, labelled with LIVE/DEAD® 
Fixable Near-IR stain (Molecular Probes, Invitrogen) 
and suspended in FACS buffer. Acquisition of flow 
cytometry data was performed as described above.  
 
Actin quantitation 
Images of serial sections of HBMEC 
stained with phalloidin were thresholded 
(Intermodes setting) and fluorescence area 
quantified in ImageJ. Quantitation of actin was 
applied to apical sections for the ruffling data.  
 
Statistical analysis 
All experiments were repeated three times 
and performed in duplicate or triplicate. GraphPad 
Prism Version 6 software was used for statistical 
analysis. For comparison of data from two 
experimental conditions, the two-tailed Student’s t 
test was used to test statistical significance. For 
multiple comparisons, statistical significance was 
tested using one-way analysis of variance followed 
by the Newman-Keuls post-hoc test. A p value less 
than 0.05 was considered significant. In the figure 
legends, * p<0.05, ** p<0.01, *** p<0.001. 
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Figure Legends 
Figure 1. E. coli K1 recruits actin to invade HBMEC. A-D. HBMEC cells were infected with E. coli K1 for 30 
min, fixed and stained with differential permeabilisation for bacteria and actin. External bacteria are shown in 
purple, bacteria that stained only after permeabilisation (i.e. internalised bacteria) are blue, actin in green. Scale 
bar 5 µm. A. Projected z stack of group of cells, shown in B at higher magnification from a single confocal slice in 
xy and xz dimensions. Note actin cup (yellow arrowhead) around central bacterium. C. Internalised bacteria 
(white arrowhead) surrounded by actin (yellow arrowhead), D. Internalised bacteria (white arrowhead) no longer 
colocalising with actin. E. Cells were pretreated with cytoskeleton-disrupting agents for 30 min, then infected with 
E. coli K1 for 1 hr. Internalised bacteria were assayed by colony counting and normalised to the appropriate mock 
treatment, either RPMI alone or with DMSO. Cyt D, cytochalasin D; Jasp, jasplakinolide; Bleb, blebbistatin; NZ, 
nocodazole; concentrations as shown. Data shown are mean ± SEM from two independent experiments with 
three replicates each. *** p<0.001 compared to related mock treatment. 
 
Figure 2. Rho family GTPases alter E. coli K1 invasion dynamics and are recruited onto bacterial 
vacuoles. A. Graphs showing quantitation of GFP-GTPase-expressing HBMEC containing intracellular bacteria 
following 2 hr infection at moi ~100. In each graph, the data is normalised to the transfection control cells 
expressing GFP only in the left column, then the columns in order indicate data from cells expressing the GFP-
tagged wild type (WT) GTPase, those expressing the dominant positive mutant and the right column the dominant 
negative GTPase. Cells expressing dominant positive Rho GTPases show a significant increase in number of 
infected mutant-expressing cells, while cells expressing the inactive mutant of Rac1 and RhoA show an inhibition 
in bacterial invasion as compared to the GFP control. Data shown are mean ± SEM of 3 independent experiments 
normalised to soluble GFP transfection control. No significant difference was found in number of intracellular 
bacteria per cell. B shows xy view of cell containing intracellular bacteria either enclosed in a cdc42-labelled 
vacuole (white arrow) or without cdc42 label (yellow arrowhead). C shows the corresponding orthogonal view. D 
The effect of kinase inhibitors (IPA-3, GF109203X, wortmannin) on E. coli K1 infection (1 hr) and on uptake of 
transferrin and dextran markers (30 min) was assayed by colony counting and by flow cytometry, respectively, 
and normalised to the control. Data shown are mean ± SEM of 2 independent experiments each with triplicate 
samples. # data not shown owing to overlapping emission spectra of kinase inhibitor and fluorescent marker. *** 
p<0.001 
 
Figure 3. E. coli K1 invasion of HBMEC is inhibited upon cholesterol depletion. A. HBMEC cells were 
pretreated with methyl-β-cyclodextrin (MbCD) or loaded with cholesterol at indicated concentrations 30 min before 
infection with E. coli K1 for 1 hr. Internalised bacteria were assayed by colony counting and normalised to control 
treatment (SFM). B. HBMEC cells were pretreated as in A, then labelled with FITC-dextran and transferrin-Alexa 
Fluor 647 for 30 min at 37°C. 10,000 cells were analysed by flow cytometry and normalised to untreated cells. 
Data shown are mean ± SEM from two independent experiments with three replicates each. * p<0.05, ** p<0.01, 
*** p<0.001 
 
Figure 4. Manipulation of caveolae function does not alter E. coli K1 invasion. A. Confocal image of 
intracellular bacterium associated with caveolin-1 following infection with E. coli K1 for 30 min and cell fixation. 
DAPI labels DNA in the host cell and the bacteria. Arrow indicates association of caveolin-1 around invading 
bacteria while arrowheads indicate bacteria without specific caveolin-1 association. Scale bar 5 µm. B. 
Quantification from micrographs of intracellular bacteria associated with caveolin-1 following infection for the time 
indicated. A decrease in the percentage of bacteria associated with caveolin-1 was observed, although very few 
bacteria are associated with caveolin-1 even at the earliest timepoint. C. GFP-tagged caveolin-1 mutant 
constructs inhibit caveolae-dependent uptake of cargo or bacteria. HBMEC cells were transiently transfected with 
caveolin-1-GFP chimaeras: wild type (WT) or phosphorylation mutant (Tyr14) as indicated. LDLR A18 GFP was a 
transfection control. GFP-expressing cells were scored for the presence of intracellular E. coli K1 following 
infection for 2 hr. There was no statistically significant difference seen in bacterial invasion between cells 
expressing caveolin-1 WT and caveolin-1 Tyr14 (or other caveolin-1 mutants, not shown). D. Mouse lung 
endothelial cells (MLEC) isolated from wild type and caveolin-1 knockout mice were infected with either E. coli K1 
or non-pathogenic E. coli K-12 for 2 hr, then bacterial invasion analysed by cfu assay. E. Uptake of E. coli K1 for 
2 hr following siRNA depletion of caveolin-1. Protein expression was quantitated by Western blotting of samples 
and relative expression determined against negative siRNA (data not shown). Actin was used as a loading 
control. Data shown are mean ± SD of 2 or 3 independent experiments each with triplicate samples. * p<0.05 
 
Figure 5. Manipulation of dynamin activity inhibits bacterial invasion of HBMEC. A. HBMEC cells transiently 
transfected with GFP-tagged dynamin constructs were infected with K1-Cherry for 2 hr. GFP-expressing cells 
were scored for the presence of intracellular E. coli K1. Soluble GFP was an experimental control. No statistically 
significant difference was seen between control, wild type and mutant dynamin, indicating that overexpression of 
dominant negative dynamin 1 and 2 did not inhibit E. coli K1 invasion of HBMEC. B. As for A, following infection 
with L. monocytogenes. C. HBMEC cells were pretreated for 30 min with dynasore at concentrations shown, then 
infected with either E. coli K1 or L. monocytogenes for 1 hr. Internalised bacteria were assayed by colony 
counting and normalised to the appropriate control (RPMI with DMSO). D. Uptake of E. coli K1 for 2 hr following 
siRNA depletion of dynamin 2. Protein expression was quantitated by Western blotting of samples and relative 
expression determined against negative siRNA (data not shown). Actin was used as a loading control. Data 
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shown are mean ± SEM of 2 or 3 independent experiments each with triplicate samples. * p<0.05, ** p<0.01, *** 
p<0.001 
 
Figure 6. Macropinocytic uptake of E. coli K1. A. HBMEC cells were labelled with FITC-dextran in either 
experimental medium (low serum) or experimental medium supplemented with 20% serum (high serum) or 
infected with E. coli K1 in low serum experimental medium for 2 hr at 37°C. Cells were then analysed by flow 
cytometry for uptake of FITC dextran. Data shown are mean of triplicates ± SEM of one representative 
experiment. P values are from pairwise statistical analysis of 3 independent experiments. B. The effect of 
macropinocytosis inhibitors (EIPA and rottlerin) on 1 hr infection of HBMEC by E. coli K1 and on 30 min uptake of 
transferrin and dextran markers was assayed by colony counting and by flow cytometry, respectively, and 
normalised to the DMSO control. Data shown are mean ± SEM of 2 or 3 independent experiments each with 
triplicate samples. C. Confocal micrograph shows that intracellular bacteria colocalise with Alexa Fluor 647-
dextran (white arrow) following 30 min infection of E. coli K1 while extracellular bacteria (yellow arrowhead) do 
not. Inset shows the corresponding orthoganol view of the internalised bacterium. D. Quantification of internalised 
bacteria colocalising with dextran as in C. Data shown are mean ± SEM from two independent experiments. 
 
Figure 7. Effect of inhibition of clathrin-mediated endocytosis on E. coli K1 invasion. A. Uptake of 
L. monocytogenes and E. coli K1 for 1 hr, following pretreatment of HBMEC with the indicated concentrations of 
chlorpromazine (CPZ) for 30 min, was assayed by colony counting and normalised to the RPMI control. ** p<0.01, 
*** p<0.001  B. HBMEC cells transfected with siRNA as indicated were infected with E. coli K1 for 2 hr following 
pretreatment for 30 min with EIPA or with DMSO as a control and assayed by colony counting. Average AP2 
knockdown was 76% ± 1%. Data shown are mean ± SEM of 2 independent experiments each with triplicate 
samples. C. Cells transfected with siRNA were infected with E. coli K1 for 30 min or 120 min (control was 
uninfected). Western blot of cell extracts shows total and phosphorylated Akt, AP2 and actin loading control for 
one experiment. Average AP2 knockdown was 83% ± 2.8%. D. Phosphorylated Akt relative to total Akt was 
quantified for 3 independent experiments. Data shown are mean ± SEM. 
 
Figure 8. Model for E. coli K1 internalisation in HBMEC. E. coli K1 enter cells through an actin-dependent, 
cholesterol-dependent process, involving activation of Rho GTPase signalling pathways. Clathrin-mediated 
endocytosis may contribute indirectly through the uptake of LDL-derived cholesterol, or through control of 
receptor cycling. 
 
Supplementary Information 
Movie S1. Timelapse movie of actin in HBMEC in response to E. coli K1 infection. Cells expressing Lifeact-
GFP (green) were infected with K1-mCherry at moi ~100. There is approx. 5 min time lag between centrifugation 
of bacteria onto cells and initiation of imaging. Images were captured at 27 sec intervals. Arrows indicate example 
cells where actin-based membrane ruffling was induced.  
 
Movie S2. Timelapse movie S1 also showing K1-mCherry (red). 
 
Figure S1. E. coli K1 induces membrane ruffling in HBMEC. A. Stills from timelapse Movie S1 (upper panel) 
and S2 (lower panel) at the times shown, demonstrating cells with increased actin ruffling at the plasma 
membrane (arrows). The area in the white square is enlarged in B to show an internalised bacterium remaining 
stationary inside the cell over time. At the end of the time series the internalised bacterium can be seen clearly in 
the orthogonal section (z view). C. Number of internalised bacteria associated with actin at given timepoints after 
infection quantified from data as in Figure 1. D. Cells were infected with either E.	  coli K1 or non-pathogenic E.	  coli 
K-12 strains for 15 min, fixed and stained for actin. Actin in apical sections (excluding stress fibres) was 
quantitated in ImageJ. Data shown are mean ± SEM of 2 independent experiments.  
	  
Figure S2. Transferrin uptake into HBMEC is inhibited by mutant dynamin expression while E. coli K1 
shows no colocalisation with dynamin. A. HBMEC cells were transiently transfected with dynamin constructs, 
then labelled with transferrin-Alexa Fluor 555. Transferrin uptake was imaged after 30 min. In cells transfected 
with the Dyn2(aa)K44A construct, transferrin uptake is inhibited (GFP cells are outlined in the transferrin images). 
Scale bar 5 µm. B. Transferrin uptake was quantitated as total fluorescence per cell in GFP-positive cells, 
normalised to cells expressing the wild type construct. Data shown are mean ± SEM of 2 independent 
experiments. C. HBMEC cells were transiently transfected with GFP-tagged dynamin constructs, then infected 
with K1-Cherry for 2 hr. The confocal micrographs show adherent and internalised bacteria, as indicated, in cells 
expressing Dyn2(aa)WT-GFP both in the xy plane and the orthogonal section. Concentration of dynamin 2 is not 
observed around invading bacteria. External and internalised bacteria denoted by yellow and white arrowheads, 
respectively. Scale bar 5 µm. 
	  
Figure S3. Transferrin uptake into HBMEC is inhibited by CME inhibitors while E. coli K1 shows no 
colocalisation with clathrin. A. Uptake of transferrin and dextran markers was assayed by flow cytometry 
following pretreatment of HBMEC with either 30 µM CPZ or 80 µM dynasore and normalised to the RPMI or 
DMSO control, respectively. Data shown are mean ± SEM of 3 independent experiments each with duplicate 
samples. * p<0.05, *** p<0.001  B. HBMEC cells were infected with L. monocytogenes or E. coli K1 for 30 min, 
then fixed and stained for internalised bacteria and clathrin. 	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